Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation has improved to more natural-looking results and is complemented by effective non-surgical treatments, with ongoing research into hair follicle cloning.

Surgeons should evaluate new technologies critically, offer a range of services including non-surgical options, and be aware of marketing influences to meet patient needs and maintain a successful practice.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Wound healing involves three phases and various cells and factors, with scars typically forming in adults. Chronic wounds can occur due to various issues, and abnormal scarring can lead to hypertrophic or keloid scars. Emerging research areas include the role of proteins, microRNAs, macrophage manipulation, and stem cell treatment.

Alopecia areata is caused by the immune system attacking hair follicles.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Alopecia areata causes patchy hair loss due to the immune system attacking hair follicles.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

JAK inhibitors are effective treatments for alopecia areata.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Alopecia areata in children requires thorough diagnosis and treatment due to its impact on quality of life and link to other autoimmune diseases.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Janus kinase inhibitors show promise for treating alopecia areata in children.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

Skin conditions like seborrheic dermatitis can make it harder to correctly diagnose hair loss because they can cause the oil glands in the skin to shrink.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Baricitinib is a promising treatment for alopecia areata.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.